BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Sana Biotechnology Reports Second Quarter 2022 Financial Results and Business Updates

  Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines, reported financial results and business highlights for the second quarter 2022.

  August 4, 2022

   · 

  19 min read
• Business

  Allakos Provides Business Update and Reports Second Quarter 2022 Financial Results

  Allakos Inc., a biotechnology company developing lirentelimab and AK006 for the treatment of allergic and inflammatory diseases, provided a business update and reported financial results for the second quarter ended June 30, 2022.

  August 4, 2022

   · 

  7 min read
• Business

  electroCore Announces Record Second Quarter 2022 Financial Results

  electroCore, Inc., a commercial-stage bioelectronic medicine company, announced second quarter 2022 financial results and provided an operational update.

  August 4, 2022

   · 

  13 min read
• Business

  Profound Medical Announces Second Quarter 2022 Financial Results

  Profound Medical Corp., a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, reported financial results for the second quarter ended June 30, 2022.

  August 4, 2022

   · 

  11 min read
• Biotech Beach

  Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA

  Exagen Inc., a leading provider of autoimmune testing solutions, announced the launch of a prospective clinical study designed to validate a novel and minimally invasive genomic diagnostic test for rheumatoid arthritis using the AVISE® RADR platform.

  August 4, 2022

   · 

  5 min read
• Business

  Kronos Bio Reports Recent Business Progress and Second-Quarter 2022 Financial Results

  Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer and other serious diseases, reported recent business progress and second-quarter 2022 financial results.

  August 4, 2022

   · 

  7 min read
• Business

  Exagen Inc. Reports Second Quarter 2022 Results

  Exagen Inc., a leading provider of autoimmune testing solutions, reported financial results for the quarter ended June 30, 2022.

  August 4, 2022

   · 

  9 min read
• Biotech Bay

  GBT Announces New Employment Inducement Grants - Aug 04, 2022

  Global Blood Therapeutics, Inc. announced that on August 1, 2022, the compensation committee of GBT’s board of directors granted 10 new employees restricted stock units for an aggregate of 30,450 shares of the company’s common stock.

  August 4, 2022

   · 

  1 min read
• Business

  NextCure Provides Business Update and Reports Second Quarter 2022 Financial Results

  NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, reported second quarter 2022 financial results and provided a business update.

  August 4, 2022

   · 

  7 min read
• Business

  NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results

  NGM Biopharmaceuticals, Inc., a clinical-stage biotechnology company focused on discovering and developing transformative therapeutics for patients, provided business highlights and reported financial results for the quarterly period ended June 30, 2022.

  August 4, 2022

   · 

  10 min read